Related Experiment Videos
New derivatives of blue dextran binding and stabilizing human or mouse interferons
Archivum Immunologiae Et Therapiae Experimentalis
|January 1, 1984
Summary
Mouse and human interferons bind strongly to Blue Dextran 2000 and its derivatives. This binding stabilized antiviral activity, with interferon-beta showing the highest affinity for these novel carriers.
Area of Science:
- Biochemistry
- Immunology
- Materials Science
Background:
- Interferons (IFNs) are crucial cytokines in the innate immune response.
- Blue Dextran 2000 (BD) is a polysaccharide widely used in biochemical applications.
- Developing stable carriers for therapeutic proteins like interferons is of significant interest.
Purpose of the Study:
- To investigate the binding affinity of mouse and human interferons to Blue Dextran 2000 and its novel derivatives.
- To evaluate the impact of these carriers on the stability of interferon antiviral activity.
Main Methods:
- Synthesis of eight new Blue Dextran derivatives (compounds VII-XIV) covalently bound to Dextran 2000.
- Assessment of binding affinity between interferons (IFN-beta, IFN-alpha, IFN-gamma) and Blue Dextran/derivatives.
- Evaluation of the stability of interferon antiviral activity when stored with the carriers at 4°C.
Main Results:
- Strong binding was observed between interferons and Blue Dextran 2000 and its derivatives.
- The binding affinity followed the order: IFN-beta > IFN-alpha > IFN-gamma.
- The carriers significantly stabilized the antiviral activity of beta-type interferon during cold storage.
Conclusions:
- Blue Dextran 2000 and its derivatives serve as effective binding carriers for interferons.
- These carriers enhance the stability of interferon antiviral activity, particularly for IFN-beta.
- The findings suggest potential applications of these novel carriers in interferon-based therapeutics and research.